Drugs / N-Acetyl-GED-0507-34-Levo
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07389109 | Dec 2024 → Apr 2026 overdue | acne | PPM Services S.A. | Active not recruiting | No outcome recorded |
| Phase 3 | NCT07384195 | Nov 2024 → Mar 2026 overdue | acne | PPM Services S.A. | Active not recruiting | No outcome recorded |
| Phase 3 | NCT07384208 | Nov 2024 → Mar 2026 overdue | acne | PPM Services S.A. | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | N-Acetyl-GED-0507-34-LEVO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07389109 ↗ |
| Route | Topical | “apply a fingertip unit of N-Acetyl-GED-0507-34-Levo 5% gel as a thin film, once daily (OD), to the entire facial skin area” NCT07384195 ↗ |